HRT Through Skin Patch Sees Fewer Gallbladder Problems Than Oral Administration

July 12th, 2008 | Category: Womens Health

A new study published on bmj.com reports that although hormone replacement therapy (HRT) results in an overall increase in risk of gallbladder disease, HRT administered by skin patches or gels poses a smaller risk than HRT given orally. In 2005,

about 1 million women in the UK were taking HRT - any of several medications designed to artificially raise estrogen, progesterone, and sometimes testosterone levels in menopausal women.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • FDA Approves Update To Label On Birth Control Patch
  • Pain Killer Skin Patch Gets Second FDA Safety Warning
  • FDA Issues Second Safety Warning On Fentanyl Skin Patch
  • Arpida Enrols First Patients In “Intravenous-to-Oral” Switch Trial With Oral Iclaprim
  • Women Prefer Contraceptive Ring by Patch - Multi-Center Study Of Contraceptive Devices Reported In Obstetrics And Gynecology

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.